MaxCyte | 8-K: MaxCyte Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Financial Results
MaxCyte Expects Q4 Core Revenue Of $8.3M-$8.5M Vs $7.2M YoY And FY24 Core Revenue Of $32.2M-$32.4M Vs $29.8M YoY
MaxCyte Reports 2024 Financial Growth and Industry Milestones
Express News | MaxCyte Inc: Core Revenue for Full Year Is Expected to Be Between $32.2 Mln and $32.4 Mln
Press Release: MaxCyte Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Financial Results
MaxCyte Expands Common Stock Issuance to 105.7 Million Shares
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
